The Physical AI Shift in Post-Acute Care: Inside Inspiren's $500M+ Bet
Dr. Dereck Mush, MD, MBA
Sonde Health
Uses a few seconds of speech to track changes in mental fitness and health over time.
What they do
Sonde Health builds vocal biomarker technology that listens for subtle changes in speech linked to depression, anxiety, cognitive change and respiratory conditions. Its platform is licensed into apps and devices so health checks can run quietly in the background of products people already use.
The record
- Vertical
- Mental & Behavioural Health
- Sub-segment
- Voice biomarkers
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- Boston, Massachusetts
- Region
- North America
- Founded
- 2015
- Total funding
- $53M raised
Notable investors: PureTech Health, M Ventures.
Also in Mental & Behavioural Health
Related on The Signal
Dr. Dereck Mush, MD, MBA
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBA
The Digital Health Valuation Reset: How Sword Health's Acquisition of Headspace Redefines Enterprise Whole-Person Care
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
The FDA asked hard questions about AI therapy chatbots. It has not yet answered them
Dr. Dereck Mush, MD, MBA